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tumor of the maxilaJose V. Bagan *, Jose M. Sanchis, Yolanda Jime´nez,
Judith Murillo, Rafael Poveda, Jose M. DiazValencia University, University General Hospital, 46014 Valencia, SpainReceived 8 December 2004; accepted 9 December 2004Summary We present a case of a malignant peripheral nerve sheath tumor
[MPNST] of the maxilla corresponding to a 12 year old male who had a painful, ulcer-
ated rapid growing tumor. Histology revealed the presence of a tumor consisting of
fusiform cells with abundant mitosis, with negative cytokeratins, actin, desmin,
myoglobin and factor VIII. In contrast, the protein S-100 was positive. MPNST was
not associated with signs of Neurofibromatosis Type 1. The patient was surgically
intervened and received radiotherapy, then died within 10 months posterior to sur-
gical intervention after suffering recurrence.c 2005 Published by Elsevier Ltd.
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3Introduction
Malignant peripheral nerve sheath tumors [MPNSTs]
are very rare malignant neoplasias. They have been
described so much to be in association with type 1
Neurofibromatosis1 and isolated forms also.2 It
deals with a malignant lesion originated from the
neural tissue that shows significant histological
likeness to fibrosarcoma. Differential diagnosis is741-9409/$ - see front matter c 2005 Published by Elsevier Ltd.
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E-mail address: bagan@uv.es (J.V. Bagan).facilitated when the patient presents a previous
history of fibromatosis. MPNTS is characterized by
the presence of very irregularly shaped cells with
nuclei that exhibit a ‘‘wavy, buckled appearance’’.
Tissue organization shows great variability, with
hypocellular myxoid areas and areas of major cel-
lularity.1 The histologic changes of MPNST include
spindle cells with comma-shaped nuclei, tactoid
bodies, nuclear palisading, hyaline bands, and
schwannoma-like and curlicue foci.3
Cases of MPNSTs have been reported mostly in
the soft tissues,4 less common in the bones5 and
very rare in the maxilla.1,6 The aim of this article
is to present a case of MPNSTs in the maxilla
showing its clinico-pathologic characteristics and
evolution.
Figure 2 Orthopantomography. An osteolytic area in
the apical area of the canine and the premolars.
Figure 3 Maxillofacial CAT scan with a lythic lesion in
the right part of the maxilla, with destruction of the
bone.
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A twelve year old male patient with a history of
having pneumonia 10 years previously and occa-
sional cephaleas since the age of 3. Visited our con-
sultation service of Stomatology at the University
General Hospital of Valencia for presenting pain
in the superior maxilla for the past 2 months.
Upon intraoral examination a well delimited and
rapid growing tumor was appreciated in the upper
jaw, on the right side (Fig. 1), of 23 cm in size
and with mobility of the superior right canine and
both premolars of the same side.
Orthopantomography (Fig. 2), computerized
axial tomography (CAT) and blood tests were re-
quested and incisional biopsy of the tumor was per-
formed. An osteolytic zone in the apical area of the
canine and the premolars were appreciated in the
orthopantomography. Maxillofacial CAT scan re-
vealed a lythic lesion in the right part of the max-
illa, with destruction of the bone of the hard
palate. It was very poorly delimited (Fig. 3). Blood
analysis was normal in the three hematologic ser-
ies, so as the hemostatic variables. Sedimentary
rate (SED) was 59 mm in the first hour (normal ref-
errence values of: 1–13). Alkaline phosphatase and
calcium levels were normal.
Histopathologic studies revealed a solid tumor,
extensively necrotized, consisting of fusiform cells
and epithelial cells with marked pleomorphism,
bizarre and multinucleated giant cells, observing
abundant mitosis (6 mitosis/10HPF) (Figs. 4 and
5). The diagnosis was sarcoma of a high grade
malignancy, extensively necrotized. Immunohisto-
chemical studies showed tumor cells negative for
cytokeratines, actin, desmin, myoglobin and Factor
VIII. It was positive to Vimentin and Protein S-100.Figure 1 Tumor in the right upper jaw.
Figure 4 A solid tumor, extensively necrotized, con-
sisting of fusiform cells and epithelial cells with marked
pleomorphism (HE 100·).
Figure 5 High view of the fusiform cells and pleomor-
phism (HE 400·).
72 J.V. Bagan et al.All of which lead to the diagnosis of malignant
peripheral nerve sheath tumor of the maxilla.
With this diagnosis the patient was surgically
intervened performing a hemimaxillectomy and
resectioning borders free of tumor. The patient la-
ter received radiotherapeutic treatment. In spite
of everything the patient suffered a relapse on
the same original area, died 10 months after surgi-
cal intervention.Discussion
In spite of being uncommon, malignant peripheral
nerve sheath tumors have been described in differ-
ent locations of the body, occasionally associated
or not with Neurofibromatosis type 1. Thus, iso-
lated cases in the orbit,7 neck,8 parapharyngeal re-
gion,2 colon,9 pancreas,10 duodenum,11 thyroid
gland,12 vulva13 and uterus14 have been reported.
On occasions the existence of the tumor is related
to the presence of Neurofibromatosis or von Rec-
klinghausen’s disease, with described cases located
in the bladder,15 thorax,16 orbit,17 mediastinum18
and prostate.19
Two series of MPNSTs of the head and neck have
been presented. Loree et al.20 informed of 17 cases
in 9 men and 8 women, whose mean survival in 5
years was 52%, seven of them was associated to
Neurofibromatosis type 1. Vege et al.21 presented
27 patients with the average age of 42 years, with
lesions in which 44.6% of the cases were in the
neck. 18.5% of the patients had distant metastases
and survival within 5 years was at 33%.
Primary MPNTSs in the bones are exceptionally
rare.5 In this concept isolated cases in the spinalcolumn22 and femur5 have been reported. Neville
et al.1 presented two cases of primary MPNSTs in
the maxilla, both of which were associated to a
neurofibromatosis type 1. The first patient was a
27 year old woman with a painful tumor lesion in
the superior maxilla. Radiology revealed an osteo-
lytic area which includes the alveolar bone and
the right maxillary sinus. The second case corre-
sponded to another woman, however of 74 years
old, that also consulted the clinic for presenting a
painful tumoral mass, although this time in the
mandible.
Our case, different from the two cases pre-
sented by Neville et al.1 was a 12 year old male,
but with a clinical case very similar to the first case
of those described by the previous authors, since it
dealt with a superior maxillary tumor on the right
side, of rapid growth, with an ulcerated surface
and with significant osteolysis evidenced in both
orthopantomography and the CAT scan. Histopa-
thologic studies revealed fusiform cells with epith-
eloid habit, marked nuclear pleomorphism and
abundant mitosis, for which the tumor was cata-
logued as a sarcoma. The negativity for epithelial,
muscular and vascular markers, so as the positivity
for protein S-100 established the final diagnosis of
MPNST.
After immunohistochemical studies of 12 MPNST
cases Mawrin et al.23 suggested that alterations in
the protein P53 play an important role in the con-
trol of the cellular reproductive cycle and the pro-
duction of tumors, both in sporadic cases of MPNST
and in those associated with neurofibromatosis.
The recommended treatment of this type of sar-
coma is the surgical extirpation including wide
margins and complementary radiotherapy.24 How-
ever, the prognosis is poor.1,21 In this perspective,
Wenabo et al.24 demonstrated that the mean sur-
vival of his 28 cases with MPNSTs was 44 months.
If a patient, in conjunction with MPNSTs has a neu-
rofibromatosis type 1, the prognosis is better;
although Loree et al.20 think otherwise.
Just as what happened to both maxillary bone
cases presented by Neville et al.1 the evolution of
our patient was poor. Dying within ten months in
spite of the performed treatments.References
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